We are live on ! Find out more
EHI

Eagle Health Investments Portfolio holdings

AUM $603M
1-Year Est. Return 111.06%
This Fund
S&P 500
This Quarter Est. Return
-10.28%
1 Year Est. Return
+111.06%
3 Year Est. Return
+240.87%
5 Year Est. Return
+290.92%
10 Year Est. Return
–
AUM
$454M
AUM Growth
-$81M
Cap. Flow
-$13M
Cap. Flow %
-2.86%
Top 10 Hldgs %
72.29%
Holding
27
New
–
Increased
7
Reduced
5
Closed
4

Top Buys

Rank Stock Value
1
TMDX icon
Transmedics
TMDX
+$13.1M
2
DXCM icon
DexCom
DXCM
+$12.8M
3
LNTH icon
Lantheus
LNTH
+$12M
4
SRPT icon
Sarepta Therapeutics
SRPT
+$8.69M
5
INSP icon
Inspire Medical Systems
INSP
+$5.14M

Top Sells

Rank Stock Value
1
CTLT
CATALENT, INC.
CTLT
+$19.9M
2
ISRG icon
Intuitive Surgical
ISRG
+$13.7M
3
GH icon
Guardant Health
GH
+$8.45M
4
ILMN icon
Illumina
ILMN
+$8.01M
5
TNDM icon
Tandem Diabetes Care
TNDM
+$7.86M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ICLR icon
1
Icon
ICLR
$12.9B
$45.9M 10.1%
186,200
– –
DHR icon
2
Danaher
DHR
$146B
$43.4M 9.57%
197,496
+3,384
+2% +$755K
IQV icon
3
IQVIA
IQV
$40B
$40.5M 8.93%
206,095
-13,400
-6% -$2.91M
UTHR icon
4
United Therapeutics
UTHR
$22.7B
$38.6M 8.5%
170,838
– –
ARGX icon
5
argenx
ARGX
$54.2B
$31.7M 6.98%
64,400
– –
LNTH icon
6
Lantheus
LNTH
$6.59B
$29M 6.38%
416,700
+163,500
+65% +$12M
NTRA icon
7
Natera
NTRA
$46.4B
$26.4M 5.81%
595,694
– –
DXCM icon
8
DexCom
DXCM
$33.2B
$25.8M 5.68%
276,105
+113,705
+70% +$12.8M
ALNY icon
9
Alnylam Pharmaceuticals
ALNY
$29B
$24.2M 5.34%
136,756
– –
TMDX icon
10
Transmedics
TMDX
$3.05B
$22.7M 5%
414,205
+182,173
+79% +$13.1M
SRPT icon
11
Sarepta Therapeutics
SRPT
$1.79B
$21.1M 4.65%
174,212
+76,872
+79% +$8.69M
INSP icon
12
Inspire Medical Systems
INSP
$1.73B
$18.5M 4.08%
93,243
+20,400
+28% +$5.14M
OM icon
13
Outset Medical
OM
$94M
$16.3M 3.58%
99,634
+19,608
+25% +$4.63M
ILMN icon
14
Illumina
ILMN
$29B
$16.2M 3.57%
121,203
-48,725
-29% -$8.01M
ISRG icon
15
Intuitive Surgical
ISRG
$138B
$12.7M 2.79%
43,390
-43,900
-50% -$13.7M
PRCT icon
16
Procept Biorobotics
PRCT
$1.26B
$11.1M 2.44%
337,218
– –
AGIO icon
17
Agios Pharmaceuticals
AGIO
$1.94B
$6.62M 1.46%
267,630
– –
ADPT icon
18
Adaptive Biotechnologies
ADPT
$4.09B
$6.62M 1.46%
1,214,860
– –
GH icon
19
Guardant Health
GH
$22.8B
$6.07M 1.34%
204,861
-240,300
-54% -$8.45M
FDMT icon
20
4D Molecular Therapeutics
FDMT
$572M
$5.57M 1.23%
437,911
– –
PNT
21
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$2.04M 0.45%
306,142
– –
CMAX
22
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$1.52M 0.33%
23,825
– –
FUSN
23
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$1.51M 0.33%
579,769
-100,601
-15% -$323K
AMWL icon
24
American Well
AMWL
$232M
– –
-69,752
Closed -$2.93M
TNDM icon
25
Tandem Diabetes Care
TNDM
$1.57B
– –
-320,325
Closed -$7.86M
1
2

Similar funds

PIFP
Partners in Financial Planning Salem, Virginia $603M AUM 12.72% 1-Year Est. Return
IECM
Intrinsic Edge Capital Management Chicago, Illinois $603M AUM 66.97% 1-Year Est. Return
ERWM
Elk River Wealth Management Denver, Colorado $602M AUM 22.77% 1-Year Est. Return
CIG
Capricorn Investment Group Palo Alto, California $602M AUM 165.22% 1-Year Est. Return
JHCP
Jackson Hole Capital Partners Tulsa, Oklahoma $605M AUM 22.77% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
OCAM
Onex Canada Asset Management Toronto, Ontario, Canada $601M AUM 15.16% 1-Year Est. Return

Eagle Health Investments's Q3 2023 Portfolio in Review

As of Q3 2023, Eagle Health Investments held 27 positions worth $454M, down 15% from $535M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Eagle Health Investments's Q3 2023 filing shows 7 increased, 5 reduced and 4 closed positions. The largest sale was CATALENT, INC., an estimated $19.9M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Eagle Health Investments added most to Transmedics in Q3 2023, an estimated $13.1M increase.
  • Eagle Health Investments's biggest Q3 2023 reduction was Intuitive Surgical, cutting an estimated $13.7M.
  • Eagle Health Investments fully exited CATALENT, INC. in Q3 2023, selling an estimated $19.9M.
  • Eagle Health Investments's ten largest holdings make up 72% of its $454M portfolio in Q3 2023.
  • Eagle Health Investments opened 0 new positions and closed 4 in Q3 2023.
  • Eagle Health Investments's portfolio value fell 15% quarter-over-quarter to $454M.

Based on Eagle Health Investments's 13F filing for Q3 2023, filed 27 Oct 2023.